Imaging is essential for evaluating patients with glioblastoma. Traditionally a multimodality undertaking, CT, including CT cerebral blood profusion, PET/CT with traditional fluorine-18 fluorodeoxyglucose (18F-FDG), and MRI have been the mainstays for diagnosis and post-therapeutic assessment. However, recent advances in these modalities, in league with the emerging fields of radiomics and theranostics, may prove helpful in improving diagnostic accuracy and treating the disease.
影像学对于评估胶质母细胞瘤患者至关重要。传统上采用多模态成像技术,包括CT(含脑血流灌注CT)、传统氟-18氟代脱氧葡萄糖(18F-FDG)PET/CT以及MRI,这些技术一直是诊断及治疗后评估的主要手段。然而,这些成像技术的最新进展,结合新兴的放射组学与诊疗一体化领域,有望提升诊断准确性并优化疾病治疗方案。
Advances in the Radiological Evaluation of and Theranostics for Glioblastoma